Celularity Inc. Interest and Dividend Income, Securities, Operating, Other
Celularity Inc. (CELU) reported Interest and Dividend Income, Securities, Operating, Other of $996.08 thousand for the 12-month period ending 2020-12-31, per its 10-K/A filed 2021-05-24.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InterestAndDividendIncomeSecuritiesOther · last filed 2021-05-24
- Celularity Inc. interest and dividend income, securities, operating, other for fiscal 2020 was $996.08K, a 61.10% decline from fiscal 2019.
- Celularity Inc. interest and dividend income, securities, operating, other for fiscal 2019 was $2.56M.
| Period end | Interest and Dividend Income, Securities, Operating, Other 12 month |
|---|---|
| 2020-12-31 | $996.08K 10-K/A · filed 2021-05-24 |
| 2019-12-31 | $2.56M 10-K/A · filed 2021-05-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |